Target intelligence / Profile preview

Prothymosin alpha pseudogene 10 (PTMAP10)

Target: PTMAP10
Molecular classification: Other (Processed pseudogene; not a receptor, enzyme, transporter, transcription factor, or ion channel)

Overview

Prothymosin alpha pseudogene 10 (PTMAP10) is one of several processed pseudogenes in the prothymosin alpha gene family. It is not known to produce a functional protein and shows no evidence of being expressed as mRNA in human tissues. Only the PTMA gene is functional; PTMAP10 and other pseudogenes have no confirmed biological activity or clinical relevance[1].

Other names: PTMAP10prothymosin alpha pseudogene 10

Mechanism of action

no mechanism; not a drug target

Beyond the preview

Go deeper on Prothymosin alpha pseudogene 10 (PTMAP10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prothymosin alpha pseudogene 10 (PTMAP10).

Explore the full profile